2670:TSEABC-MART, INC. Analysis
Data as of 2026-07-27 - not real-time
HK$159.50
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Beijing Yunji Technology’s share price sits at HK$159.5, well below its 20‑day SMA of 188.6 and the 200‑day SMA of 187.3, signaling a bearish backdrop despite a recent bullish MACD crossover (MACD line -30.2 above signal -32.2) and a modest positive histogram. The 14‑day RSI of 34.7 places the stock in oversold territory, while volume is on a decreasing trend and 30‑day volatility spikes above 120%, suggesting heightened price swings. A beta of 0.63 points to lower systematic risk, yet the Fear & Greed Index at 88.09 marks “Extreme Greed,” implying that market sentiment may be overly optimistic.
Fundamentally, the company posted a 28.5% revenue surge but suffers from severe profitability issues, with operating and net margins near –82% and –98% respectively, and negative free cash flow exceeding HK$1.9 billion. Valuation metrics are extreme: a forward P/E of 918×, price‑to‑book of 11.2×, and price‑to‑sales of 36.7× contrast sharply with an industry P/E average of 31.4×, while the consensus target price of HK$148.7 implies a downside of about 7%. The balance sheet appears solid with minimal debt (debt‑to‑equity 0.04) and ample cash (HK$773 million), but operating cash flow remains negative, and no dividend is offered.
Fundamentally, the company posted a 28.5% revenue surge but suffers from severe profitability issues, with operating and net margins near –82% and –98% respectively, and negative free cash flow exceeding HK$1.9 billion. Valuation metrics are extreme: a forward P/E of 918×, price‑to‑book of 11.2×, and price‑to‑sales of 36.7× contrast sharply with an industry P/E average of 31.4×, while the consensus target price of HK$148.7 implies a downside of about 7%. The balance sheet appears solid with minimal debt (debt‑to‑equity 0.04) and ample cash (HK$773 million), but operating cash flow remains negative, and no dividend is offered.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Oversold RSI indicating potential further price decline
- Current price above target price and high valuation multiples
- Decreasing volume and extreme volatility increasing downside risk
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong revenue growth offering upside if margins improve
- Continued cash burn and negative operating cash flow
- Support level near HK$134 providing a floor for price action
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- Potential market leadership in commercial service robots in China
- Low debt and substantial cash cushion to fund restructuring
- Long‑term secular demand for automation across hospitality, retail, and healthcare
Key Metrics & Analysis
Financial Health
Revenue Growth28.50%
Profit Margin-97.89%
P/E Ratio918.2
ROA-15.61%
Debt/Equity0.04
P/B Ratio11.2
Op. Cash FlowHK$-169818000
Free Cash FlowHK$-1975962496
Industry P/E31.4
Technical Analysis
TrendNeutral
RSI34.7
SupportHK$134.00
ResistanceHK$327.80
MA 20HK$188.56
MA 50HK$260.78
MA 200HK$187.27
MACDBullish
VolumeDecreasing
Fear & Greed Index88.09
Valuation
Target PriceHK$148.67
Upside/Downside-6.79%
GradeOvervalued
TypeBlend
Risk Assessment
Beta0.63
Volatility124.93%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.